Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
The Pediatric Infectious Disease Journal|May 29, 2025
Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 ResultsHelena Rabie, Dwight E Yin, Shawn Ward, et al.Journal of Thrombosis and Haemostasis : JTH|February 12, 2023
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factorEinas Elsheikh, Michelle Lavin, Lilian Antunes Heck, et al.Blood|December 24, 2023
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studiesFerdows Atiq, Robin Blok, Calvin B van Kwawegen, et al.The Lancet. HIV|August 4, 2023
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation studyKristina M Brooks, Jennifer J Kiser, Lauren Ziemba, et al.Molecular Oncology|December 23, 2023
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023Ulrik Ringborg, Joachim von Braun, Julio Celis, et al.Blood|April 25, 2025
Clinical phenotype and pathophysiological mechanisms underlying qualitative Low VWFFerdows Atiq, Robin Blok, Calvin van Kwawegen, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 15, 2021
Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: A phase 2 randomized clinical trialMichael T Brennan, Lars Siim Madsen, Deborah P Saunders, et al.Autophagy|June 26, 2018
Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence: supporting the next generation of autophagy researchers and fostering international collaborationsVojo Deretic, Eric Prossnitz, Mark Burge, et al.Molecular Oncology|December 15, 2025
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities: Proceedings from a conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City, May 22-23, 2025Ulrik Ringborg, Joachim von Braun, Julio Celis, et al.Autophagy|June 26, 2019
Autophagy, Inflammation, and Metabolism (AIM) Center in its second yearVojo Deretic, Eric Prossnitz, Mark Burge, et al.Pageof 11